Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Wyeth Pharmaceuticals, Inc.
Current Parent Company: Pfizer
Penalty: $257,400,000
Year: 2013
Date: July 30, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-Scandal: Improper Drug Marketing
Violation Description: Wyeth agreed to pay $257.4 million to settle multistate litigation alleging that it promoted the sale and use of the kidney transplant drug Rapamune for uses not approved by the U.S. Food and Drug Administration. This was part of a larger $490.9 million civil and criminal settlement also involving the federal government, which issued its own announcement; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.